Pazufloxacin

Chemical compound
  • J01MA18 (WHO)
Identifiers
  • (3R)-10-(1-aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-1H,7H- [1,3]oxazino[5,4,3-ij]quinoline-carboxylic acid
CAS Number
  • 127045-41-4 checkY
PubChem CID
  • 65957
ChemSpider
  • 59360
UNII
  • 4CZ1R38NDI
CompTox Dashboard (EPA)
  • DTXSID5046697 Edit this at Wikidata
ECHA InfoCard100.162.962 Edit this at WikidataChemical and physical dataFormulaC16H15FN2O4Molar mass318.304 g·mol−13D model (JSmol)
  • Interactive image
  • C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2C4(CC4)N)F)C(=O)O
InChI
  • InChI=1S/C16H15FN2O4/c1-7-6-23-14-11(16(18)2-3-16)10(17)4-8-12(14)19(7)5-9(13(8)20)15(21)22/h4-5,7H,2-3,6,18H2,1H3,(H,21,22)/t7-/m0/s1
  • Key:XAGMUUZPGZWTRP-ZETCQYMHSA-N
  (verify)

Pazufloxacin (INN) is a fluoroquinolone antibiotic.[1] It is sold in Japan under the brand names Pasil and Pazucross.

See also

  • Quinolones

References

  1. ^ Rubinstein E (2001). "History of quinolones and their side effects". Chemotherapy. 47 Suppl 3 (3): 3–8, discussion 44-8. doi:10.1159/000057838. PMID 11549783. S2CID 21890070.
  • v
  • t
  • e
Antibacterials that inhibit nucleic acid (J01E, J01M)
Antifolates
(inhibit bacterial
purine metabolism,
thereby inhibiting
DNA and RNA
synthesis)
DHFR inhibitor
Sulfonamides
(DHPS inhibitor)
Short-acting
Intermediate-acting
Long-acting
Other/ungrouped
Combinations
Other DHPS inhibitors
Quinolones
(inhibit bacterial
topoisomerase
and/or DNA gyrase,
thereby inhibiting
DNA replication)
1st generation
Fluoroquinolones
2nd generation
3rd generation
4th generation
Veterinary
Newer non-fluorinated
Related (DG)
Anaerobic DNA
inhibitors
Nitroimidazole derivatives
Nitrofuran derivatives
RNA synthesis
Rifamycins/
RNA polymerase
Lipiarmycins
Stub icon

This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e